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ABSTRACT
Introduction: To assess excess use of coronary
angiography prior to coronary artery bypass
graft surgery and its association with mortality,
health care costs, and hospital quality in
Turkey.
Methods: Using Turkish National Health
Insurance Data (2009–2011) that included
patients who underwent cardiac surgery,
coronary angiography utilization was identified.
Propensity score matching was used to compare
survival rates and annual health care costs of
patients in a coronary angiography excess-use
group ([1 angiogram) and in a standard-therapy
group (1 angiogram). The empirical Bayesian
approach was used to combine mortality and
hospital volume for quality index. The
relationship between hospital quality and excess
use of coronary angiography was assessed using
Chi-squared tests.
Results: Out of 20,126 patients identified,
7.27% of patients underwent excessive
coronary angiography procedures (excess-use
group), with an average annual cost at 9.7%
higher than those who had a single angiography
(standard-therapy group; P\0.01). Operational
mortality associated with excessive use was
significantly higher as well (7.4% versus 5.4%,
P\0.02). There exists variation in the use of
coronary angiography across cities and
hospitals. Patients who underwent cardiac
surgery in high-quality hospitals were less
likely to have excessive angiography use than
those in low-quality hospitals (7.0% versus
9.5%, P\0.01).
Conclusion: In Turkey, excess use of coronary
angiography prior to coronary artery bypass
graft surgery is associated with higher
O. Baser (&)
STATinMED Research and The University
of Michigan, 211. N. Fourth Avenue, Ann Arbor,
MI 48104, USA
e-mail: obaser@statinmed.com
A. Burkan  R. Koselerli  E. Ertugay
Social Security Institution, Ankara, Turkey
E. Baser
Central Bank of Turkey, Ankara, Turkey
A. Altinbas
Gastroenterology Clinic, Dıskapı Yıldırım Beyazıt
Education and Research Hospital, Ankara, Turkey
Enhanced content for this article is
available on the journal web site:
www.cardiologytherapy-open.com
123
Cardiol Ther (2013) 2:151–163
DOI 10.1007/s40119-013-0018-z
operational mortality, higher expenditures, and
lower hospital quality.
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INTRODUCTION
Coronary artery bypass graft (CABG) surgery is
one of the most common surgical procedures
performed to relieve angina symptoms in
patients with coronary artery disease [1, 2].
The surgery improves the quality of life and
survival rates of patients with coronary artery
disease [3–5].
Coronary angiography is considered the
standard procedure for CABG assessment [6].
Every year, millions of patients get an
angiogram, wherein a long, thin, flexible tube
called a catheter is inserted in the arm or groin,
and threaded to the heart to check for blocked
arteries that may lead to a heart attack. Dye is
injected through the tube to make blockages
visible on X-rays [7]. Although angiographies
are effective in select populations, the overall
appropriateness of their use is questioned [8–
10]. The test carries a small (\1%), but serious,
risk of causing a stroke or heart attack, and also
entails radiation exposure [11].
The troubling association between the
increased number of CABG surgeries and high
frequency of costly angiograms to check for
heart disease has caused payers to request studies
to outline the benefits, risks, and outcomes of
these procedures. The cost of these procedures
will be major contributors to increased health
care spending [12]. Prior studies have indicated
that excess use of and increased costs associated
with these procedures are related to variation in
the quality of care [13].
This study aimed to demonstrate the
variation in the use of coronary angiography
for patients who underwent CABG surgery in
Turkey using nationwide, real-world data. The
difference in mortality rates and annual health
care costs associated with coronary angiography
overuse was calculated. The correlation between
the number of angiographies and hospital
quality based on a previously validated claims-
based quality index was estimated.
METHODS
MEDULA, a nationwide integrated system
shared between general health insurance and
health care providers, was used for the analysis.
Claims from 17,800 pharmacies, 5,600 general
practitioners, 4,500 medical centers, 1,200
government hospitals, and 338 private
hospitals are recorded in the data, covering
over 80% of the population in Turkey.
All patients aged 18–99 years who underwent
CABG surgery between April 1, 2009 and
October 1, 2010 were identified using
procedure codes from the International
Classification of Diseases Tenth Revision
Clinical Modification. Patients were assigned
to ‘‘standard-therapy’’ or ‘‘excess-use’’ groups if
they had only one or more than one coronary
angiography, respectively, within 3 months of
their first CABG diagnosis date (index date)
during the identification period. Patients were
required to be continuously enrolled 3 months
prior to the index date and 12 months
following the index date.
The first aim was to examine the extent to
which overuse of coronary angiography varied
geographically across cities and hospitals. The
second aim was to assess the association of
coronary angiography excess use with
operational mortality, higher expenditures,
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and hospital quality. Descriptive analyses were
performed to compare risk factors, including
demographic, clinical, and provider
characteristics of coronary angiography
patients. Demographic information regarding
age, gender, and geographic region was
available in the dataset.
The Elixhauser Index score was calculated to
measure comorbidity burden [14]. This index is
based on a comprehensive set of 30
International Classification of Diseases Ninth
Revision Clinical Modification comorbidity
flags. The detailed list is provided in the
Table 4 of Appendix. To conceptually identify
important comorbidities, the Elixhauser Index
attempted to exclude information relating to
other aspects of a patient’s condition. For
example, a secondary diagnosis is considered
to be comorbid only when it is not directly
related to the principal diagnosis.
Complications were eliminated by excluding
codes that reflect acute conditions. Therefore,
in the Elixhauser Index, a number of diagnoses
that may have been considered comorbidities
were not counted, because certain conditions,
such as pneumonia, pleural effusion, urinary
tract infection, cardiac arrest, cardiogenic
shock, and respiratory failure, were not
distinguishable from complications that may
have resulted from diagnostic or therapeutic
interventions during hospitalization.
Unimportant comorbidities were also
eliminated because those such as benign
prostatic hypertrophy, inguinal hernia, and
diverticulitis do not significantly impact
resource use or mortality, if they were not the
principal diagnosis. Current coding for the
Elixhauser Index is available from the Agency
for Healthcare Research and Quality and is
widely used in outcomes research [15].
Acuity admission and the Elixhauser Index
score were used as a proxy for severity. The
cardiac surgery volume and teaching hospital
status were derived as provider characteristics.
Health care utilization, mortality and health
care costs were available in the dataset. Health
care reimbursement amounts were converted to
Euros. (1€ = 2.34 TRY, May 15, 2013).
This article does not contain any studies
with human or animal subjects performed by
any of the authors.
Statistical Analysis
Paired t tests and Chi-square tests were used to
compare the demographic, clinical, and
provider characteristics between the two
groups: standard-therapy group and excess-use
group. To estimate risk-adjusted differences in
mortality and annual health care costs with the
overuse of angiography, the propensity score
matching (PSM) method was used. This
technique, employed by the predicted
probability of group membership, isolates the
observed bias from the estimation [16].
Following previously published guidelines for
choosing the most appropriate matching
technique for the present data, one-to-one
matching with caliber was used [17]. Caliber
was selected as 25% of the standard errors of the
estimated propensity score.
Using regression analysis, mortality rates and
total health care costs for patients with standard
therapy and excess use were also estimated. In
particular, Cox regression was used for
operational mortality estimation, and
generalized linear models were used for total
health care cost estimation for both groups.
Hospital quality was characterized by a
previously validated composite score, which
combines operational mortality with hospital
volume information using Bayesian techniques
[18]. Hospital procedure volume was assessed as
the total number of procedures performed by
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each hospital. Operational mortality was
defined as death occurring before discharge or
within 30 days of surgery. The authors
calculated risk-adjusted hospital mortality
using regression analysis. After testing the fit of
several transformations, hospital volume was
modeled as natural log of the continuous
volume variable. Using this regression model,
the authors estimated the volume-predicted
mortality for each hospital, and ratio of the
number of actual to expected deaths was then
determined. The number of expected deaths was
the sum of the patients of the predicted
probability of death, derived from a logistic
regression model estimated for all patients
undergoing surgery. The dependent variable in
the logistic regression was death, and the
independent variables were patient
demographic and clinical factors. The derived
index is presented in quartiles to rank low- to
high-quality hospitals. Since this index
combines information from multiple quality
domains into a single measure, it has been
referred to as the ‘‘gold standard’’ for hospital
performance comparisons on US national
standards of safety, quality, and efficiency that
are most relevant to patients and payers [19–21].
All statistical analyses were conducted using
SAS V.9.3 (SAS Institute Inc., North Carolina,
USA) and STATA V11 (StataCorp LP, Texas,
USA). In particular, SAS V.9.3 is used for data
management, and STATA V11 is used for
statistical analysis.
RESULTS
A total of 20,126 patients satisfied all inclusion
criteria, of which, 88.12% (n = 17,734)
underwent CABG surgery after one coronary
angiography (standard-therapy group), and
7.27% (n = 1,464) had more than one
coronary angiography (excess-use group)
within 3 months prior to CABG surgery. The
distribution of excess use is presented in Fig. 1.
Few CABG surgery patients (4.61%) did not
utilize coronary angiography prior to surgery.
Most subjects were 45–64 years, and 27.01%
of the cases were female. Patients most
frequently resided in the Marmara Region
(36.64%), followed by Central Anatolia
(25.36%), the Mediterranean (12.47%), and the
Aegean region (10.55%). Nearly one-third of the
sample had comorbidity scores C2 (32.17%).
Less than 1% of these patients were admitted
into the emergency care settings. The majority
of surgeries were performed in high-volume
hospitals (58.75%), and 11.16% of the surgeries
occurred in teaching hospitals (Table 1).
Geographic variation in coronary
angiography use is presented in Fig. 2. To
increase the reliability of the estimate, cities
with\20 angiography procedures were not taken
into consideration in the rates. The proportion of
CABG surgery patients with excess use was the
highest in Erzurum (13.36%), followed by
Batman (12.28%), and Antalya (11.95%).
Thirty-six out of 81 cities did not have centers
for coronary angiography, and 1,288 patients
underwent CABG surgery without having a
coronary angiography. A total of 33.17%
Fig. 1 Distribution of excess use of angiography ([1
angiography) for patients who underwent CABG surgery in
hospitals across Turkey. CABG coronary artery bypass graft
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(n = 68) of hospitals had excess use rates below
5%, while 5.37% (n = 11) of hospitals had excess
use rates exceeding 20% (Fig. 3).
Compared with standard-therapy patients,
excess-use patients were less likely to be between
the ages of 45 and 64 years (51.50% versus
54.85%, P\0.02), female (25.27% versus
27.30%, P\0.1), to reside in the Southeastern
Anatolia region (4.30% versus 6.24%, P\0.003),
and have their surgery in high-volume hospitals
(Table 2). However, patients in the excess-use
group resided in the Mediterranean region more
frequently than those in the standard-therapy
group (15.57% versus 12.28%, P\0.001).
Patients who underwent CABG surgery in
teaching hospitals were more likely to have
more than one coronary angiography prior to
surgery (14.41% versus 10.43%, P\0.0001).
After PSM, 1,464 patients were matched
between patients in the excess-use and
standard-therapy groups. Matched patients
were similar in terms of their demographic,
clinical, and provider characteristics (Table 3).
Over the matched sample, where differences in
demographic, clinical, and provider differences
were adjusted, operational mortality (7.4%
versus 5.4%, P\0.03) and annual health care
costs were significantly higher for the excess-use
group relative to the standard-therapy group
(€8,737 versus €7,963, P\0.01).
After controlling for baseline demographic
and clinical factors in the regression models, the
results were consistent with PSM models.
Operational mortality (5.7% versus 4.4%,
P\0.01) and annual health care costs (€8,634
versus €7,852, P\0.01) were significantly
higher for the excess-use group relative to the
standard-therapy group.
Hospital quality was strongly associated with
excess use. Only 7.0% of patients in hospitals
with the highest quality rating were in the
excess-use group within 30 days of CABG
surgery, whereas the rate was significantly
higher for low-quality hospitals (9.5%,
P\0.01; Fig. 4).




Number of patients 20,126
Patient characteristics






Gender (% female) 5,436 27.01
Admission acuity (% emergency
care)
13 0.06




Central Anatolia 5,084 25.26
Mediterranean 2,509 12.47
Black Sea 1,222 6.07
Eastern Anatolia 589 2.93
Southeastern Anatolia 1,224 6.08
Provider characteristics
Teaching hospital 2,246 11.16
Hospital volume quartiles
Q1 (low) 1,465 7.28
Q2 2,234 11.10
Q3 4,602 22.87
Q4 (high) 11,825 58.75
CABG Coronary artery bypass graft, SD standard deviation
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For the complete overview of the study
population, patients who did not receive the
angiography were also compared with the main
study groups. After applying risk adjustment,
standard-therapy patients use had lower
mortality rates (3.96% versus 6.01%, P\0.010)
and incurred lower annual health care costs
(€7,850 versus €8,081, P\0.010) relative to
patients who did not have angiography.
Patients with excess use of angiography
incurred higher annual health care costs
(€8,695 versus €8,148, P\0.010) and had no
significant operational mortality rate advantage
(5.74% versus 6.09%, P = 0.675), relative to
patients without angiography use.
DISCUSSION
Several studies reported on variations in the
utilization of cardiac procedures [20–25]. These
studies showed that variation is related to age,
gender, racial, and geographic factors.
In this study, angiography utilization in a
disease-specific (CABG surgery) cohort of
patients with uniform insurance coverage in
Turkey was examined. Results determined that
after adjusting for demographic and clinical
factors, there was significant variation in
coronary angiography use. Regional practice
patterns emerged, showing that more
procedures were performed in cities such as
Erzurum, Batman and Antalya, relative to the
rest of Turkey.
Current guidelines for patients undergoing
assessment for obstructive coronary artery
disease are designed to limit the number of
invasive angiographies and thereby enhance
the diagnostic yield of cardiac catheterization
[26]. However, a substantial increase in these
procedures has contributed to a rise in medical
costs. Several factors are responsible for this
increase, including wider availability of
technology, increased demand by patients and
physicians, and favorable reimbursements [27].
Fig. 2 Excess use of coronary angiogram ([1 angiography) for CABG patients across cities in Turkey. CABG coronary
artery bypass graft, Q quarter
Fig. 3 Hospital distribution in the probability of excess
use ([1 angiography) adjusted by patient characteristics
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In Turkey, due to the implementation of the
Health Transformation Program by the Ministry
of Health in the last decade, the health status of
the Turkish population has improved
significantly [28]. Therefore, the rise in
procedure utilization is expected. However, the
association with excess use and hospital quality
is of particular interest. Often, coronary
Table 2 Demographic, clinical, and provider characteristics of CABG patients with (excess-use group) and without
(standard-therapy group) excess use of angiography
Demographics Standard-therapy group Excess-use group P value
n % n %
Number of patients 17,374 1,464
Patient characteristics
Age mean (SD) 62.16 (9.63) 62.36 (9.99) 0.4614
18–30 12 0.07 2 0.14 0.3624
31–44 572 3.29 58 3.96 0.1712
45–64 9,530 54.85 754 51.50 0.0134
65–74 5,419 31.19 481 32.86 0.1871
C75 1,841 10.60 169 11.54 0.2595
Gender (% female) 4,743 27.30 370 25.27 0.0941
Admission acuity (% emergency care) 10 0.06 1 0.07 0.8701
Elixhauser index 5,513 31.73 527 36.00 0.0008
Regions
Aegean 1,818 10.46 152 10.38 0.9221
Marmara 6,347 36.53 545 37.23 0.5959
Central Anatolia 4,398 25.31 346 23.63 0.1550
Mediterranean 2,134 12.28 228 15.57 0.0003
Black Sea 1,078 6.20 85 5.81 0.5428
Eastern Anatolia 515 2.96 45 3.07 0.8126
Southeastern Anatolia Region 1,084 6.24 63 4.30 0.0029
Provider characteristics
Teaching (%) 1,812 10.43 211 14.41 \0.0001
Hospital volume quartiles
Q1 (low) 1,241 7.14 110 7.51 0.5974
Q2 1,882 10.83 198 13.52 0.0016
Q3 3,955 22.76 393 26.84 0.0004
Q4 (high) 10,296 59.26 763 52.12 \0.0001
CABG Coronary artery bypass graft, SD standard deviation
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angiography is done in the urban centers. When
patients move to higher volume hospitals for
CABG surgery, the procedure is repeated,
yielding excess use of this invasive and risky
procedure. Problems may arise when physicians
fear missing something or doing too little. This
attitude has developed a culture where
individuals feel that doing more tests and
knowing more are always the proper course.
Therefore, communication between
angiography centers and health care
professionals must become more efficient, in
order to determine which patients should be
subjected to the cost and risk of an angiogram.
Patients may question their doctors about the
need for the second test, as well as any risks or
Table 3 Demographic, clinical and provider characteristics of CABG patients with and without excess use of angiography
after propensity score matching
Demographics Standard-therapy group Excess-use group P value
n % n %
Number of patients 1,464 1,464
Patient characteristics
Mean age (SD) 62.58 (9.8) 62.36 (9.99) 0.5475
18–31 3 0.20 2 0.14 0.5392
31–44 57 3.89 58 3.96 0.8908
45–64 754 51.50 754 51.50 0.9999
65–74 481 32.86 481 32.86 0.9999
C75 169 11.54 169 11.54 0.9999
Gender (female, %) 370 25.27 370 25.27 0.9999
Admission acuity (% emergency care) 1 0.07 1 0.07 0.9999
Elixhauser index (% with 2 and above) 526 35.93 527 36.00 0.9555
Regions
Aegean 152 10.38 152 10.38 0.9999
Marmara 545 37.23 545 37.23 0.9999
Central Anatolia 346 23.63 346 23.63 0.9999
Mediterranean 228 15.57 228 15.57 0.9999
Black Sea 85 5.81 85 5.81 0.9999
Eastern Anatolia 45 3.07 45 3.07 0.9999
Southeastern Anatolia Region 63 4.30 63 4.30 0.9999
Provider characteristics
Teaching (%) 210 14.34 211 14.41 0.9392
Hospital volume
High volume 763 52.12 763 52.12 0.9999
SD standard deviation
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alternative options. The annual health care
costs for the excess-use group were 9.7%
higher than for standard-therapy group.
Mortality rates were 1.37 times higher.
Hospital quality was assessed using a
previously validated composite score, which
has been applied by a large group of coalitions
in the United States [19, 21]. Traditional quality
indicators, whether they are based on structure,
process, or direct outcomes measures, have
significant limitations. For example, hospital
volume is important for high-risk procedures
but does not reliably predict performance for
individual hospitals. Process measures often fail
to explain observed variations in hospital
mortality rates. Direct outcomes measures,
because of sample size limitations, are often
imprecisely estimated and do not produce a
reliable estimate of hospital performance. The
composite measure used in this study has the
potential to obviate these limitations, because it
combines information from surgical volume and
operational mortality into a single summary
measure. This study presents a negative
relationship between high-quality hospitals
and excess use of coronary angiography.
Numerous studies have been done to
evaluate factors that may influence the results
of a variety of surgical procedures. Almost
invariably, when assessed, surgeon experience
is an important factor in determining the
likelihood of successful outcomes from
surgery. For example, in shoulder replacement
procedures, a surgeon who performs 30
replacements over 6 years is considered ‘‘high
volume’’ [29]. These doctors had lower
complication rates and their patients had
shorter hospital stays than ‘‘low volume’’
surgeons. In hip replacement surgery, surgeons
who performed fewer than 30 hip replacements
each year had more patients requiring revision
surgery [30]. In another study, 5 years of
scoliosis surgery experience did not improve
outcomes [31]. Therefore, it is difficult to define
a specific number of procedures that deem a
surgeon proficient. In the present study, the
authors empirically determined the effect of
the volume of procedures by including them in
the hospital quality index.
The present study has several strengths. To
the authors’ knowledge, this is the first study in
Turkey that includes a large, diverse, and
geographically varied sample of patients who
received coronary angiography before CABG
surgery. It is also the first study that shows the
relationship between hospital quality and the
excess use of coronary angiography. Excess costs
associated with angiography overuse and
operational mortality are also presented for
the first time in Turkey.
Data were limited in their clinical
information related to disease severity in
coronary angiography patients. The Elixhauser
Index and admission acuity were used in the
attempt to control for differences. These
measures are not representative of disease
severity; therefore, the impact of severity on
coronary angiography excess use may be
underestimated. Although claims data are
extremely valuable in revealing the real-world
practice of procedures and determining
Fig. 4 Excess use of coronary angiogram ([1 angiography)
and hospital quality. Q quarter
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associated costs, these data are collected for
payment purposes rather than research.
Presence of a diagnosis code on a medical
claim is not necessarily proof of disease
presence, as diagnoses may be miscoded.
Random miscoding would not affect the
present results; however, if it is systematically
related to hospitals or geographic regions, then
the study results would be biased. The
magnitude of miscoding and its effect on the
extent of variation remains unclear.
Risk adjustment was performed using PSM,
and although the method is widely used in
outcomes research, it controls only observed
bias. Regression analysis is another technique to
control for observable bias. There has been some
discussion about which method should be chosen
to remove observable bias [32]. Proponents of the
PSM method outline several advantages of the
technique over regression analysis. First, without
involving the outcome variable in the selection
process, PSM can design observational studies in
an analogous way, compared with the way
randomized clinical trials are designed [33].
Regression analysis uses the outcome as a left-
hand-side variable, which is not supposed to be
available during randomization. Second,
confounding by treatment variables is often the
main challenge to validity, and the propensity
score focuses directly on treatment variables [34].
Third, a matched analysis can eliminate non-
comparable exposed subjects [35]. Finally, PSM
provides robust estimates when there are
relatively few outcomes to compare with the
number of potentially few outcomes [36–38].
Proponents of regression analysis, however,
focus on statistical advances in regression
literature [39, 40]. Deciding on a matching
algorithm and obtaining standard errors for
inference through matching are more
complicated than conducting regression
analysis. Little of the existing literature examines
this process. Thus, careful regression analysis with
good controls and flexible functional forms is
often the most accurate.
In this paper, the authors applied both PSM
and regression analysis, and the results were
similar. Shah et al. compared the PSM method
and traditional regression modeling in
observational studies. Among 78 exposure-
outcome associations in 43 studies evaluated,
statistical significance differed in only 10% of
cases [41]. Stu¨rmer et al. [42] compared 69
studies and found that in only 13% of the
studies, PSM estimates differed by more than
20% from the regression model. In the present
example, due to excess use, 1.37 times the
associated risk increase in operational
mortality in PSM results decreased to 1.29
times in traditional regression analysis.
Associated cost differences in PSM analysis
increased from €774 to €782, compared with
traditional regression analysis. PSM and
traditional regression analyses yielded
significant differences in outcomes between
the standard-therapy and excess-use groups.
Consistent with the Shah et al. and Stu¨rmer
et al. studies, comparison estimates between the
two techniques were not significantly different.
Unobserved bias can occur due to missing
disease severity information and the use of
advanced techniques, such as the instrumental
variable approach [43]. However, these
techniques are bounded by their own
limitations [44, 45].
CONCLUSION
Efforts to curb the growth of health care spending
in Turkey inevitably require a decrease in the
variation of quality health care. A systematic
examination of excess use of invasive procedures
is an essential step in targeting cost-reduction
160 Cardiol Ther (2013) 2:151–163
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efforts along with improving health care quality.
By analyzing real-world data, this study showed
that there exists a variation in coronary
angiography use in Turkey. Excess use of
coronary angiography prior to CABG surgery is
associated with higher operational mortality
expenditures and lower hospital quality.
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APPENDIX
See Table 4.
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The original Deﬁnitions of comorbidities were given in a
1998 article by Elixhauser et al. [14]; however, these
deﬁnitions have been updated. See (http://www.hcup-us.
ahrq.gov/toolssoftware/comorbidity/comorbidity.jsp)
(accessed May 28, 2013) to reﬂect the changes in the codes
to deﬁne the comorbidities. We used the updated version
in this study
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